EYEPOINT PHARMACEUTICALS INC (EYPT) Institutional Ownership and Insiders Activity
EYEPOINT PHARMACEUTICALS INC (EYPT) is widely held by institutional investors, with 179 firms reporting positions valued at approximately $1.24B based on SEC Form 13F filings for the quarter ended June 30, 2026.
Suvretta Capital Management, Llc is the largest disclosed holder, reporting approximately $118.64M in EYPT holdings in its latest filing.
Recent insider activity includes 7 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.
Institutional Holders
179
Total Reported Value
$1.24B
Largest Holder
Suvretta Capital Management, Llc
Largest Position
$118.64M
Insider Transactions (90d)
7
Latest Filing Quarter
Q2 2026
New Institutional Positions
27
Funds Exiting Positions
33
Top Institutional Owners
View allInvestorReported Balance
- Suvretta Capital Management, Llc$118.64M
- Blackrock, Inc.$106.72M
- Cormorant Asset Management, Lp$100.10M
- Federated Hermes, Inc.$81.24M
- Adage Capital Partners Gp, L.L.C.$69.04M
EYPT News
All news- Essex Woodlands Portfolio Concentration: An All-Healthcare Holding Analysis
Aug 7, 2026 · valut.ai
Related EYPT Institutional Insights:
- EYPT 13F Institutional Holders
- EYPT Top Institutional Shareholders
- EYPT Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- EYPT Insider Trading & SEC Form 4 Activity
- EYPT Articles
- Top Institutional Investor Stock Rankings